Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2050-6511
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats ; volume:13 ; number:1 ; day:17 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
BMC pharmacology & toxicology ; 13, Heft 1 (17.9.2012), 1, 9.2012

Urheber
Stilinović, Nebojša
Beteiligte Personen und Organisationen
Rašković, Aleksandar
Mikov, Momir
Vukmirović, Saša
Milijašević, Boris
SpringerLink (Online service)

DOI
10.1186/2050-6511-13-S1-A9
URN
urn:nbn:de:1111-2016073153300
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:57 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Stilinović, Nebojša
  • Rašković, Aleksandar
  • Mikov, Momir
  • Vukmirović, Saša
  • Milijašević, Boris
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice

Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy

Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy

A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators

Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators

Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis

Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis

Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α

Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α

The significance of the apelinergic system in doxorubicin-induced cardiotoxicity

The significance of the apelinergic system in doxorubicin-induced cardiotoxicity

PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis

PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis

Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice

Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity

Verbundene Objekte